Track Medtech Start-ups

Learn More
innovation hub

Alpha Cancer Technologies (aka ACT) is Profiled in this Database

Updated At 28 Jun, 2012

Start Free 7 Day Trial Now
Partial description of this company
A proprietary drug delivery platform that uses human Alpha-Fetoprotein (AFP) to deliver selective chemotherapy, avoiding damage to normal cells

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Alpha Cancer Technologies (aka ACT) plus 4787 other startups.

Start Free 7 Day Trial Now

Learn More About Alpha Cancer Technologies (aka ACT)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

More

Start Free 7 Day Trial Now

Our Clients

1-jnj.png
2-medtronic.png
3-abbott.png
4-baxter.png
5-mckinsey.jpg
7-bostonscientific.png
8-bd.png
9-smithnephew.png
10-stryker.png
33m.png
allergan.jpg
bain.jpg
bbraun.png
beckmancoulter.png
cardinal.png
depuysynthes.png
drager.png
edwardslifesciences.png
ethicon.png
ge.png
gore.png
health-advances.jpg
hospira.png
jlabs.jpg
kimberlyclark.png
merck.jpg
olympus.png
orthofix.png
philips.png
sanofigenzyme.png
teleflex.jpg
terumo.png
zimmerbiomet.png